Literature DB >> 9225962

Growth factors in human ovarian cancer.

A M Westermann1, J H Beijnen, W H Moolenaar, S Rodenhuis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9225962     DOI： 10.1016/s0305-7372(97)90024-4

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  6 in total

1.  SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.

Authors:  Neveen A Said; Ida Najwer; Matthew J Socha; David J Fulton; Samuel C Mok; Kouros Motamed
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

2.  Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

Authors:  Marie-Line Puiffe; Cécile Le Page; Abdelali Filali-Mouhim; Magdalena Zietarska; Véronique Ouellet; Patricia N Tonin; Mario Chevrette; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

3.  Disaggregation and invasion of ovarian carcinoma ascites spheroids.

Authors:  Kathryn M Burleson; Matthew P Boente; Stefan E Pambuccian; Amy P N Skubitz
Journal:  J Transl Med       Date:  2006-01-24       Impact factor: 5.531

4.  Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer.

Authors:  H Yagi; S Miyamoto; Y Tanaka; K Sonoda; H Kobayashi; T Kishikawa; R Iwamoto; E Mekada; H Nakano
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

Review 5.  Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.

Authors:  Locke D Uppendahl; Carly M Dahl; Jeffrey S Miller; Martin Felices; Melissa A Geller
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

Review 6.  Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2018-07-09       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.